Interleukin-4 adenoviral gene therapy reduces production of inflammatory cytokines and prostaglandin E2 by rheumatoid arthritis synovium ex vivo. (Q45859614)
Jump to navigation
Jump to search
scientific article published in July 1999
Language | Label | Description | Also known as |
---|---|---|---|
English | Interleukin-4 adenoviral gene therapy reduces production of inflammatory cytokines and prostaglandin E2 by rheumatoid arthritis synovium ex vivo. |
scientific article published in July 1999 |
Statements
Interleukin-4 adenoviral gene therapy reduces production of inflammatory cytokines and prostaglandin E2 by rheumatoid arthritis synovium ex vivo (English)
Woods JM
Tokuhira M
Berry JC
Katschke KJ Jr
Kurata H
Damergis JA Jr
Arai K